Cardiac Tumors: Diagnosis, Prognosis, and Treatment
Rossana Bussani(University of Trieste), Gianfranco Sinagra(University of Trieste), Vincenzo Nuzzi(University of Trieste), Federico Ferro(University of Udine), Matteo Castrichini(Mayo Clinic), Luca Restivo(University of Trieste), Linda Pagura(University of Trieste), Chiara Cappelletto(University of Trieste), Aldostefano Porcari(University of Trieste), Enrico Fabris(University of Trieste), Renata Korcova(University of Trieste), Laura Massa(University of Trieste), Riccardo Bessi(University of Trieste), Alberto Pivetta(University of Trieste), Paolo Manca(University of Trieste)
Cited by 198
Related Papers
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology
|EBioMedicine|2020|387
Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years
|Circulation|2022|226
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
|European Journal of Heart Failure|2022|197
Prevalence and Prognostic Impact of Non-Cardiac Co-Morbidities in Heart Failure Outpatients with Preserved and Reduced Ejection Fraction: A Community-Based Study
|European Journal of Heart Failure|2018|174
Transthyretin cardiac amyloidosis
|Cardiovascular Research|2022|163